Home/Filings/4/0001104659-21-094062
4//SEC Filing

COHEN ALAN S 4

Accession 0001104659-21-094062

CIK 0001805385other

Filed

Jul 19, 8:00 PM ET

Accepted

Jul 20, 6:07 PM ET

Size

16.2 KB

Accession

0001104659-21-094062

Insider Transaction Report

Form 4
Period: 2021-07-16
COHEN ALAN S
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-07-16+192,482192,482 total(indirect: By Trust)
    Exercise: $0.42Exp: 2030-08-16Class A Common Stock (192,482 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-07-16+223,979223,979 total(indirect: By Trust)
    Exercise: $0.42Exp: 2030-08-16Class A Common Stock (223,979 underlying)
  • Award

    Performance Rights

    2021-07-16+138,972138,972 total(indirect: By Trust)
    Class A Common Stock (138,972 underlying)
  • Award

    Class A Common Stock

    2021-07-16+593,908593,908 total(indirect: By Trust)
  • Award

    Stock Option (Right to Buy)

    2021-07-16+163,318163,318 total(indirect: By Trust)
    Exercise: $0.42Exp: 2030-08-16Class A Common Stock (163,318 underlying)
Footnotes (5)
  • [F1]The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement").
  • [F2]Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026
  • [F3]The option vests and becomes exercisable as to 25% of the underlying shares on October 1, 2019 and in 36 equal monthly installments thereafter.
  • [F4]The option vests and becomes exercisable as to 25% of the underlying shares on February 1, 2020 and in 36 equal monthly installments thereafter.
  • [F5]The option vests and becomes exercisable as to 25% of the underlying shares on November 19, 2020 and in 36 equal monthly installments thereafter.

Issuer

Evolv Technologies Holdings, Inc.

CIK 0001805385

Entity typeother

Related Parties

1
  • filerCIK 0001183034

Filing Metadata

Form type
4
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 6:07 PM ET
Size
16.2 KB